Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.22.2.2
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of product warranty accrual
               
    September 30, 2022     December 31, 2021  
Beginning balance   $ 46,650     $ 45,328  
Warranty claims incurred     (5,296 )     (16,075 )
Provision charged (credited) to expense     (770 )     17,397  
Ending balance   $ 40,584     $ 46,650  
Schedule of earnings per share
                       
    Three Months Ended     Nine Months Ended  
    September 30     September 30  
    2022     2021     2022     2021  
Net Income / (Loss)   $ (697,572 )   $ 17,240     $ (1,206,654 )   $ (55,616 )
Less cumulative dividends earned on Preferred stock     (23,505 )     (23,505 )     (69,743 )     (69,743 )
Net loss attributable to common shareholders   $ (721,077 )   $ (6,265 )   $ (1,276,397 )   $ (125,359 )
Schedule of weighted average diluted shares
                               
    Three Months Ended     Nine Months Ended  
    September 30     September 30  
    2022     2021     2022     2021  
Weighted average common shares outstanding - basic   $ 299,212,282     $ 136,311,335     $ 295,592,261     $ 136,311,335  
Dilutive effect of stock options                        
Weighted average common shares outstanding - diluted   $ 299,212,282     $ 136,311,335     $ 295,592,261     $ 136,311,335